Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

Share Price is delayed by 15 minutes
Get Live Data
128.50    5.40 (4.39%)
Bid:
129.50
Ask:
129.80
Spread: 0.30 (0.232%)
Market Cap: £400.10m
PAGE Live PriceLast checked at - London Stock Exchange

Intraday PageGroup Share Chart

EPT Disclosure

9 Sep 2008 07:00

RNS Number : 9941C
Deutsche Bank AG
08 September 2008
 



DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

 

1. KEY INFORMATION

Name of exempt principal trader

Deutsche Bank AG Zurich 

Company dealt in

Adecco

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary

Date of dealing

04/09/2008

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

94,354 0.05

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

150,000 0.09

-1,000,000 -0.57

Total

244,354 0.14

-1,000,000 -0.57

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Rights to subscribe (Note 2)

Class of relevant security:

Details

3. DEALINGS (Note 3)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unit - Swiss Francs

CHF

Purchase

515

50.3

Purchase

309

50.8

Purchase

309

50.85

Purchase

1

51.4

Purchase

205

51.55

Purchase

206

51.75

Purchase

360

51.8

Purchase

257

52

TOTAL Purchase

2,162

Sale

720

50.3

Sale

309

51.95

TOTAL Sale

1,029

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 5)

Number of securities (Note 6)

Price per unit (Note 4)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 6)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 4) 

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 4)

(d) Other dealings (including new securities) (Note 3)

Nature of transaction (Note 7)

Details

Price per unit (if applicable) (Note 4)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8) YES/NO

Date of disclosure

08/09/2008

Contact name

Artie Movsesian

Telephone number

020 7545 7804

Name of offeree/offeror with which connected

Michael Page International Plc

Nature of connection (Note 9)

Connected Advisor to Offeree

Notes

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMLPMPTMMBMBFP
Date   Source Headline
2nd Jan 20149:21 amRNSTotal Voting Rights
31st Dec 20139:36 amRNSHolding(s) in Company
20th Dec 20134:35 pmRNSHolding(s) in Company
16th Dec 20139:41 amRNSBlocklisting Interim Review
11th Dec 20139:57 amRNSDirectorate Change
31st Oct 201312:47 pmRNSTotal Voting Rights
14th Oct 20137:01 amRNSInterim Management Statement
14th Oct 20137:00 amRNSDirectorate Change
2nd Oct 20133:40 pmRNSNotice of Q3 Interim Management Statement
30th Sep 20134:58 pmRNSHolding(s) in Company
30th Sep 20133:10 pmRNSTotal Voting Rights
30th Aug 201312:02 pmRNSTotal Voting Rights
13th Aug 20137:00 amRNSHalf Yearly Report
2nd Aug 201312:25 pmRNSNotice of 2013 Half Year Results
31st Jul 20134:22 pmRNSTotal Voting Rights
16th Jul 20137:00 amRNSQ2 AND FIRST HALF 2013 TRADING UPDATE
5th Jul 20133:59 pmRNSNotice of Q2 2013 Trading Update
28th Jun 20133:14 pmRNSTotal Voting Rights
13th Jun 201312:08 pmRNSBlocklisting Interim Review
13th Jun 20139:40 amRNSHolding(s) in Company
6th Jun 20135:56 pmRNSResult of AGM
31st May 201311:32 amRNSTotal Voting Rights
1st May 20135:12 pmRNSDirector/PDMR Shareholding
30th Apr 20135:38 pmRNSTotal Voting Rights
30th Apr 201312:07 pmRNSAnnual Financial Report
24th Apr 20134:41 pmRNSDirector/PDMR Shareholding
16th Apr 20137:00 amRNSQ1 2013 Interim Management Statement
15th Apr 201312:14 pmRNSHolding(s) in Company
11th Apr 20135:44 pmRNSHolding(s) in Company
2nd Apr 20133:58 pmRNSNotice of Q1 2013 Interim Management Statement
2nd Apr 20132:03 pmRNSHolding(s) in Company
2nd Apr 201311:52 amRNSTotal Voting Rights
20th Mar 20139:25 amRNSHolding(s) in Company
19th Mar 201312:11 pmRNSDirector/PDMR Shareholding
18th Mar 20139:52 amRNSHolding(s) in Company
15th Mar 20132:43 pmRNSHolding(s) in Company
15th Mar 201311:18 amRNSDirector/PDMR Shareholding
14th Mar 20135:28 pmRNSDirector/PDMR Shareholding
14th Mar 20135:28 pmRNSDirector/PDMR Shareholding
14th Mar 20139:26 amRNSHolding(s) in Company
5th Mar 20137:00 amRNSFinal Results
4th Mar 20132:34 pmRNSHolding(s) in Company
1st Mar 201310:17 amRNSTotal Voting Rights
25th Feb 20132:38 pmRNSHolding(s) in Company
21st Feb 20139:50 amRNSNotice of Results
18th Feb 20137:00 amRNSBlock Listing Application
5th Feb 20139:41 amRNSHolding(s) in Company
1st Feb 201310:57 amRNSTotal Voting Rights
31st Jan 20136:43 pmRNSHolding(s) in Company
8th Jan 20138:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.